KELA - Kempisch Laboratorium - Kela Laboratoria
0403.835.645 · rovalta.com · 23/09/2026
KELA - Kempisch Laboratorium - Kela Laboratoria
Overview
What does KELA - Kempisch Laboratorium - Kela Laboratoria do?
KELA - Kempisch Laboratorium - Kela Laboratoria is a Public limited company incorporated in 1941. Its registered office is in Hoogstraten. It employs on average 261,4 ETP workers (FTE).
2320 Hoogstraten · FlandreSee on map
Joint committees (2)
- 116
- 207
Trend over 19 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||||
| Revenue | 55,2 M € | +8.9% | 50,7 M € | +7.8% | 47 M € | -0.5% | 47,2 M € | -3.3% | 48,8 M € | +2.2% | 47,8 M € | +10.6% | 43,2 M € | +6.9% | 40,4 M € | -2.7% | 41,5 M € | +0.1% | 41,4 M € | +1.3% | 40,9 M € | +3.1% | 39,7 M € | +8.6% | 36,5 M € | +7.6% | 33,9 M € | +6.2% | 32 M € | +7.1% | 29,8 M € | +4.0% | 28,7 M € | -2.7% | 29,5 M € | +16.6% | 25,3 M € |
| EBITDA | 1,8 M € | -57.8% | 4,3 M € | +301% | 1,1 M € | +703% | -177,5 k € | -104% | 4,3 M € | +125% | 1,9 M € | -29.1% | 2,7 M € | -2.7% | 2,8 M € | +9.8% | 2,5 M € | +62.5% | 1,6 M € | -51.0% | 3,2 M € | -13.0% | 3,6 M € | -0.9% | 3,7 M € | +5.3% | 3,5 M € | -32.5% | 5,2 M € | +9.1% | 4,7 M € | +41.2% | 3,4 M € | -27.6% | 4,6 M € | +24.2% | 3,7 M € |
| Operating result | -746,4 k € | -133% | 2,3 M € | +307% | -1,1 M € | +49.0% | -2,1 M € | -191% | 2,3 M € | +582% | 342,7 k € | -54.5% | 752,4 k € | -40.9% | 1,3 M € | +165% | 480,4 k € | +345% | -196 k € | -123% | 845,5 k € | -45.7% | 1,6 M € | +21.0% | 1,3 M € | +47.8% | 871,5 k € | -62.6% | 2,3 M € | +32.6% | 1,8 M € | +704% | 218,9 k € | -84.9% | 1,5 M € | +38.3% | 1 M € |
| Net result | -1,2 M € | -105% | 23,8 M € | +1160% | -2,2 M € | -289% | -575,7 k € | -148% | 1,2 M € | +40.7% | 848,3 k € | +3042% | 27 k € | -92.8% | 376,6 k € | +508% | 61,9 k € | -12.0% | 70,4 k € | -82.7% | 405,9 k € | -30.6% | 585 k € | +70.6% | 343 k € | +72.2% | 199,2 k € | -70.0% | 663,4 k € | -41.3% | 1,1 M € | +267% | -676,3 k € | -308% | 325,6 k € | -27.5% | 449 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||||
| Equity | 31,9 M € | -3.6% | 33,1 M € | +240% | 9,7 M € | -18.7% | 12 M € | -6.5% | 12,8 M € | +10.3% | 11,6 M € | +7.9% | 10,8 M € | +0.3% | 10,7 M € | +3.6% | 10,4 M € | +0.6% | 10,3 M € | +0.7% | 10,2 M € | +0.2% | 10,2 M € | +2.1% | 10 M € | +0.3% | 10 M € | +0.2% | 10 M € | +0.7% | 9,9 M € | +5.5% | 9,4 M € | +23.5% | 7,6 M € | -0.7% | 7,6 M € |
| Total assets | 63,2 M € | +1.2% | 62,4 M € | +16.3% | 53,7 M € | +3.7% | 51,8 M € | +3.9% | 49,8 M € | +4.5% | 47,7 M € | +5.3% | 45,3 M € | +7.7% | 42,1 M € | +3.5% | 40,7 M € | +3.6% | 39,2 M € | +10.4% | 35,5 M € | +6.1% | 33,5 M € | +8.1% | 31 M € | +6.2% | 29,2 M € | -7.0% | 31,4 M € | +0.1% | 31,3 M € | -3.8% | 32,6 M € | -6.6% | 34,9 M € | +0.5% | 34,7 M € |
| Cash | 1,4 M € | -82.7% | 7,9 M € | +282% | 2,1 M € | +116% | 957,6 k € | -45.0% | 1,7 M € | +66.1% | 1 M € | +27.4% | 822,4 k € | -69.1% | 2,7 M € | +231% | 805,1 k € | -31.0% | 1,2 M € | -67.9% | 3,6 M € | +100% | 1,8 M € | +16.9% | 1,6 M € | +48.2% | 1 M € | +219% | 327,8 k € | -14.8% | 384,6 k € | -61.2% | 991,8 k € | +25.5% | 790,2 k € | +74.6% | 452,5 k € |
| Debts | 30,6 M € | +6.8% | 28,7 M € | -34.2% | 43,6 M € | +10.4% | 39,5 M € | +7.1% | 36,9 M € | +2.3% | 36 M € | +4.5% | 34,5 M € | +10.7% | 31,1 M € | +3.3% | 30,1 M € | +6.2% | 28,4 M € | +13.4% | 25 M € | +9.0% | 23 M € | +11.2% | 20,6 M € | +8.2% | 19,1 M € | -10.4% | 21,3 M € | -0.1% | 21,3 M € | -7.2% | 23 M € | -15.6% | 27,2 M € | +0.7% | 27 M € |
| Other | |||||||||||||||||||||||||||||||||||||
| Workforce | 261,4 ETP | +3.0% | 253,8 ETP | +0.6% | 252,3 ETP | +2.7% | 245,6 ETP | -0.9% | 247,8 ETP | +6.5% | 232,6 ETP | +17.3% | 198,3 ETP | +8.9% | 182,1 ETP | +1.4% | 179,5 ETP | +6.0% | 169,4 ETP | +2.7% | 164,9 ETP | +5.4% | 156,4 ETP | +5.7% | 147,9 ETP | +7.1% | 138,1 ETP | +0.1% | 137,9 ETP | 0.0% | 137,9 ETP | -6.2% | 147,0 ETP | -0.9% | 148,4 ETP | -0.1% | 148,5 ETP |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 1 active · 35 ended
Other companies at this address
| Company | CBE no. |
|---|---|
KELA VETERINARIA● Active | 0412.402.527 |
Medicem● Active | 0418.885.986 |
PHENIX PROPERTY● Active | 0413.676.987 |
VOXDALE● Active | 0435.552.467 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 01/07/2026 | 30/06/2025 | 03/07/2024 | 19/07/2023 | 20/07/2022 | 19/07/2021 |
| General meeting | 02/06/2026 | 24/06/2025 | 04/06/2024 | 20/06/2023 | 24/06/2022 | 25/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
31 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 02/06/2026 | 01/07/2026 | Dutch | |
| Full model | 31/12/2024 | 24/06/2025 | 30/06/2025 | Dutch | |
| Full model | 31/12/2023 | 04/06/2024 | 03/07/2024 | Dutch | |
| Full model | 31/12/2022 | 20/06/2023 | 19/07/2023 | Dutch | |
| Full model | 31/12/2021 | 24/06/2022 | 20/07/2022 | Dutch | |
| Full model | 31/12/2020 | 25/06/2021 | 19/07/2021 | Dutch | |
| Full model | 31/12/2019 | 29/06/2020 | 02/07/2020 | Dutch | |
| Full model | 31/12/2018 | 14/05/2019 | 04/07/2019 | Dutch | |
| Full model | 31/12/2017 | 08/05/2018 | 08/06/2018 | Dutch | |
| Full model | 31/12/2016 | 09/05/2017 | 01/06/2017 | Dutch | |
| Consolidated accounts | 31/12/2016 | 09/05/2017 | 27/06/2017 | Dutch | |
| Full model | 31/12/2015 | 17/05/2016 | 23/06/2016 | Dutch | |
| Consolidated accounts | 31/12/2015 | 17/05/2016 | 17/06/2016 | Dutch | |
| Full model | 31/12/2014 | 12/05/2015 | 24/06/2015 | Dutch | |
| Consolidated accounts | 31/12/2014 | 12/05/2015 | 03/07/2015 | Dutch | |
| Full model | 31/12/2013 | 13/05/2014 | 04/06/2014 | Dutch | |
| Consolidated accounts | 31/12/2013 | 13/05/2014 | 18/06/2014 | Dutch | |
| Full model | 31/12/2012 | 14/05/2013 | 16/05/2013 | Dutch | |
| Consolidated accounts | 31/12/2012 | 14/05/2013 | 11/06/2013 | Dutch | |
| Full model | 31/12/2011 | 08/05/2012 | 01/06/2012 | Dutch | |
| Consolidated accounts | 31/12/2011 | 29/05/2012 | 28/06/2012 | Dutch | |
| Full model | 31/12/2010 | 10/05/2011 | 27/05/2011 | Dutch | |
| Consolidated accounts | 31/12/2010 | 10/05/2011 | 20/05/2011 | Dutch | |
| Full model | 31/12/2009 | 11/05/2010 | 20/05/2010 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 1 active · 35 ended
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates03/01/2025ONTSLAGEN - BENOEMINGEN
- Mandates14/05/2024ONTSLAGEN - BENOEMINGEN
- Mandates11/01/2024DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates19/05/2023ONTSLAGEN - BENOEMINGEN
- Mandates20/11/2019ONTSLAGEN - BENOEMINGEN
- Mandates25/09/2018ONTSLAGEN - BENOEMINGEN
- Mandates14/11/2017ONTSLAGEN - BENOEMINGEN
- Mandates13/02/2017ONTSLAGEN - BENOEMINGEN
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-1,2 M €↓
- 2024Annual accounts 202423,8 M €↑
- 24/10/2024nominationPascal Beyens — vast vertegenwoordiger
- 2023Annual accounts 2023-2,2 M €↓
- 2022Annual accounts 2022-575,7 k €↓
- 24/06/2022reconductionRenatus Beyers — bestuurder
- 24/06/2022nominationArnaud Clybouw — commissaris
- 2021Annual accounts 20211,2 M €↑
- 2021Name changeKEMPISCH LABORATORIUM
- 2020Annual accounts 2020848,3 k €↑
- 2019Annual accounts 201927 k €↓
- 2018Annual accounts 2018376,6 k €↑
- 2017Annual accounts 201761,9 k €↓
- 2016Annual accounts 201670,4 k €↓
- 2015Annual accounts 2015405,9 k €↓
- 2014Annual accounts 2014585 k €↑
- 2013Annual accounts 2013343 k €↑
- 2012Annual accounts 2012199,2 k €↓
- 2011Annual accounts 2011663,4 k €↓
- 2010Annual accounts 20101,1 M €↑
- 2009Annual accounts 2009-676,3 k €↓
- 2007Annual accounts 2007325,6 k €↓
- 2006Annual accounts 2006449 k €
- 2006Name changeKELA - Kempisch Laboratorium - Kela Laboratoria
- 15/07/1941IncorporationPublic limited company